Azole-resistant aspergillus fumigatus with the environmental TR46/Y121F/T289A mutation in India

Journal of Antimicrobial Chemotherapy

Volumn 69, Issue 2, 2014, Pages 555-557

  Chowdhary, Anuradha ^a   Sharma, Cheshta ^a   Kathuria, Shallu ^a   Hagen, Ferry ^b   Meis, Jacques F ^b,c  

^a UNIVERSITY OF DELHI   (India)

^b CANISIUS WILHELMINA HOSPITAL   (Netherlands)

^c RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Azole resistant A. fumigatus; Environment; Microsatellite typing

Indexed keywords

ANTIFUNGAL AGENT; BROMUCONAZOLE; CYPROCONAZOLE; DIFENOCONAZOLE; EPOXICONAZOLE; FUNGICIDE; HEXACONAZOLE; ISAVUCONAZOLE; ITRACONAZOLE; METCONAZOLE; PENCONAZOLE; POSACONAZOLE; PYRROLE; TEBUCONAZOLE; TRIADIMEFON; TRIAZOLE; UNCLASSIFIED DRUG; VORICONAZOLE;

ANTIFUNGAL ACTIVITY; ANTIFUNGAL RESISTANCE; ASPERGILLUS FUMIGATUS; AUBERGINE; CAPSICUM ANNUUM; FENUGREEK; FUNGAL GENE; FUNGAL STRAIN; FUNGUS ISOLATION; FUNGUS MUTATION; GENOTYPE; INDIA; LETTER; MICROENVIRONMENT; NONHUMAN; PHYLOGENY; POTATO; SEQUENCE ANALYSIS; SOIL ANALYSIS;

AZOLE-RESISTANT A. FUMIGATUS; ENVIRONMENT; MICROSATELLITE TYPING;

ASPERGILLUS FUMIGATUS; AZOLES; DRUG RESISTANCE, FUNGAL; HUMANS; INDIA; MUTATION; SOIL MICROBIOLOGY;

EID: 84892467182     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkt397     Document Type: Letter

References (11)

1. van der Linden JWM, Snelders E, Kampinga GA et al. Clinical implications of azole resistance in Aspergillus fumigatus, the Netherlands, 2007-2009. Emerg Infect Dis 2011; 17: 1846-52.
2. Howard SJ, Cerar D, Anderson MJ et al. Frequency and evolution of azole resistance in Aspergillus fumigatus associated with treatment failure. Emerg Infect Dis 2009; 15: 1068-76.
3. Chowdhary A, Kathuria S, Randhawa HS et al. Isolation of multipletriazole- resistant Aspergillus fumigatus strains carrying the TR/L98H mutations inthecyp51AgeneinIndia. JAntimicrobChemother2012;67:362-6.
4. Lockhart SR, Frade JP, Etienne KA et al. Azole resistance in Aspergillus fumigatus isolates from the ARTEMIS global surveillance study is primarily due to the TR/L98H mutation in the cyp51A gene. Antimicrob Agents Chemother 2011; 55: 4465-8.
5. Snelders E, Huis In 't Veld RA, Rijs AJJM et al. Possible environmental origin of resistance of Aspergillus fumigatus to medical triazoles. Appl Environ Microbiol 2009; 75: 4053-7.
6. Badali H, Vaezi A, Haghani I et al. Environmental study of azole-resistant Aspergillus fumigatus with TR34/L98H mutations in the cyp51A gene in Iran. Mycoses 2013; doi:10.1111/myc.12089.
7. Chowdhary A, Kathuria S, Xu J et al. Clonal expansion and emergence of environmental multiple-triazole-resistant Aspergillus fumigatus strains carrying the TR34/L98H mutations in the cyp51A gene in India. PLoS One 2012; 7: e52871.
8. Snelders E, Camps SM, Karawajczyk A et al. Triazole fungicides can induce cross-resistance to medical triazoles in Aspergillus fumigatus. PLoS One 2012; 7: e31801.
9. van der Linden JW, Camps SM, Kampinga GA et al. Aspergillosis due to voriconazole highly resistant Aspergillus fumigatus and recovery of genetically related resistant isolates from domestic homes. Clin Infect Dis 2013; 57: 513-20.
10. Kuipers S, Brüggemann RJ, de Sévaux RG et al. Failure of posaconazole therapy in a renal transplant patient with invasive aspergillosis due to Aspergillus fumigatus with attenuated susceptibility to posaconazole. Antimicrob Agents Chemother 2011; 55: 3564-6.
11. Vermeulen E, Maertens J, Schoemans Het al. Azole-resistant Aspergillus fumigatus due to TR46/Y121F/T289A mutation emerging in Belgium, July 2012. Euro Surveill 2012; 17: pii=20326.